Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 948-518-4 | CAS number: -
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Skin sensitisation
Administrative data
- Endpoint:
- skin sensitisation: in vivo (LLNA)
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 12 December 2018 - 12 July 2019
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 2 019
- Report date:
- 2019
Materials and methods
Test guideline
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 429 (Skin Sensitisation: Local Lymph Node Assay)
- Version / remarks:
- adopted 22 July 2010
- Deviations:
- no
- GLP compliance:
- yes (incl. QA statement)
- Type of study:
- mouse local lymph node assay (LLNA)
Test material
- Reference substance name:
- Reaction products of 2,3-epoxypropyl phenyl ether and 2,2'-iminodi(ethylamine)
- EC Number:
- 948-518-4
- Molecular formula:
- (C13H23N3O2 . C31H43N3O6)x
- IUPAC Name:
- Reaction products of 2,3-epoxypropyl phenyl ether and 2,2'-iminodi(ethylamine)
- Test material form:
- liquid
- Details on test material:
- PGE-DETA adduct
Constituent 1
- Specific details on test material used for the study:
- SOURCE OF TEST MATERIAL
- Source and lot/batch No.of test material: Olin Corporation Batch: 17-09-502-04 QM 14K17-54
- Expiration date of the lot/batch: 30 October 2019
- Purity test date: Approx. 97% (including the oligomeric isomers)
The test item was placed into an appropriate container on a tared balance and DMSO was added (weight per weight).
The different test item concentrations were prepared serially.
The preparations were made freshly before each dosing occasion.
In vivo test system
Test animals
- Species:
- mouse
- Strain:
- CBA/Ca
- Remarks:
- CBA/CaOlaHsd
- Sex:
- female
- Details on test animals and environmental conditions:
- TEST ANIMALS
- Source: Envigo RMS B.V., Inc
- Females nulliparous and non-pregnant
- Age at study initiation: 1st pre-test: 10 - 11 weeks 2nd pre-test: 8 - 9 weeks 3rd & 4th pre-test: 9 - 10 weeks Main study: 12 - 13 weeks
- Weight at study initiation: 18.3 - 23.5 g
- Housing: Grouped 5 animals per solid bottom Makrolon cage containing soft wood bedding.
- Diet: 2018C Teklad Global 18% protein rodent diet (certified), ad libitum
- Water: tap water, ad libitum
- Acclimation period: at least 5 days
ENVIRONMENTAL CONDITIONS
- Temperature (°C): 22 + 2°C
- Humidity (%): 45-65%
- Photoperiod (hrs dark / hrs light): 12/12
Study design: in vivo (LLNA)
- Vehicle:
- dimethyl sulphoxide
- Concentration:
- The definitive test was performed at concentrations of 0.01, 0.05, and 0.25% due to effects seen during a series of pretest experiments that assessed a wide range of concentrations; 0.05 - 50%.
- No. of animals per dose:
- Pretests: 1 females (nulliparous and non-pregnant) per dose group
Main test: 5 females (nulliparous and non-pregnant) per dose group - Details on study design:
- PRE-SCREEN TESTS:
- Compound solubility: Dimethylsulfoxide was evaluated as vehicle and found acceptable
- Irritation: erythema observed at concentrations of 0.05% and above,
- Systemic toxicity: No systemic toxicity was observed at any concentration
- Ear thickness measurements: Increased ear thickness > 25% was observed at concentrations of 1% and above
MAIN STUDY
ANIMAL ASSIGNMENT
The animals were distributed into the test groups at random. All animals belonging to the same experimental group were kept in one cage. In the main experiment, the animals were identified by tail tags. In the pre-experiment, animals were identified by cage number.
- Criteria used to consider a positive response:
A test item is regarded as a sensitiser in the LLNA if the following criteria are fulfilled:
• First, that exposure to at least one concentration of the test item resulted in an incorporation of 3HTdR at least 3-fold or greater than that recorded in control mice, as indicated by the Stimulation Index.
• Second, that the data are compatible with a conventional dose response, although allowance must be made (especially at high topical concentrations) for either local toxicity or immunological suppression.
TREATMENT PREPARATION AND ADMINISTRATION:
Test Item Administration
Each test group of mice was treated by (epidermal) topical application to the dorsal surface of each ear with test item concentrations of 0.01, 0.05, and 0.25% in DMSO. The application volume, 25 μL/ear/day, was spread over the entire dorsal surface (∅ ∼ 8 mm) of each ear once daily for three consecutive days. Three further groups of mice (two vehicle control groups and one positive control group) were treated with an equivalent volume of the relevant vehicle alone or with the positive control item at 25% (w/v).
Administration of 3H-methyl-thymidine
Five days after the first topical application (day 6) 250 μL of phosphate-buffered saline containing 20 μCi of 3H-methyl thymidine (equivalent to 79.9 μCi/mL 3HTdR) were injected into each test and control mouse via the tail vein.
Terminal Procedure
Approximately five hours after treatment with 3HTdR all mice were euthanized by using CO2, which was, after harvesting of the lymph nodes, followed by cervical dislocation to ensure death.
Preparation of Single Cell Suspensions
The draining lymph nodes were rapidly excised and pooled per animal (2 nodes per animal). Single cell suspensions (in phosphate buffered saline) of pooled lymph node cells were prepared by gentle mechanical disaggregation through stainless steel gauze (200 μm mesh size). After washing two times with phosphate buffered saline (approx. 10 mL) the lymph node cells were resuspended in 5 % trichloroacetic acid (approx. 3 mL) and incubated at approximately +4 °C for approximately 18 hours for precipitation of macromolecules.
Determination of cellular proliferation (incorporation of 3HTdR)
The precipitates were then resuspended in 5 % trichloroacetic acid (1 mL) and transferred to scintillation vials with 10 mL of scintillation liquid and thoroughly mixed. The level of 3HTdR incorporation was then measured in a β-scintillation counter. Similarly, background 3HTdR levels were also measured in two 1 mL-aliquots of 5 % trichloroacetic acid. The β-scintillation counter expresses 3HTdR incorporation as the number of radioactive disintegrations per minute.
Observations
Clinical Observations
All animals were observed on a daily basis, including pre- and post-dose observations on days 1, 2 and 3. Any clinical signs of systemic toxicity, local skin irritation or signs of ill health during the study were recorded. - Positive control substance(s):
- mercaptobenzothiazole (CAS No 149-30-4)
- Statistics:
- The mean values and standard deviations were calculated for body weight.
Where appropriate, the EC3 value were calculated according to the equation
EC3 = (a-c) [(3-d)/(b-d)] + c
where EC3 is the estimated concentration of the test item required to produce a 3-fold increase in draining lymph node cell proliferative activity; (a, b) and (c, d) are respectively the co-ordinates of the two pair of data lying immediately above and below the S.I. value of 3 on the local lymph node assay dose response plot. All calculations conducted on the DPM values and the ear thickness were performed with a validated test script of “R”, a language and environment for statistical computing and graphics. Within the program a statistical analysis conducted on the DPM values and the ear thickness to assess whether the difference was statistically significant between the test item groups and negative control group. Statistical significance was set at the five per cent level (p < 0.05). Additionally, the Dean-Dixon-Test and Grubb’s Test were used for identification of possible outliers. No outlier was detected. However, both biological and statistical significance will be considered together.
Results and discussion
- Positive control results:
- S.I. = 7.6 (positive)
In vivo (LLNA)
Resultsopen allclose all
- Parameter:
- SI
- Value:
- 0.7
- Test group / Remarks:
- Test Item: 0.01% in DMSO
- Parameter:
- SI
- Value:
- 0.5
- Test group / Remarks:
- Test Item: 0.5% in DMSO
- Parameter:
- SI
- Value:
- 0.3
- Test group / Remarks:
- Test Item: 0.25% in DMSO
- Cellular proliferation data / Observations:
- Calculation of the EC3 value
The EC3 value could not be calculated, since all S.I.´s are below the threshold value of 3.
Viability / Mortality
No deaths occurred during the study period
Clinical Signs
No signs of systemic toxicity were observed during the study period. From days 1 to 6, the animals showed an erythema of the ear skin (Score 1). Additionally, on day 6, scaly ears and erythema was observed.
Body Weights
There was not obvious affect of treatment on body weight. Body Weights were within the range commonly recorded for animals of this strain and age.
Ear Thickness
The measured ear thickness of all animals treated was recorded prior to the 1st application, on study day 3 and prior to necropsy (day 6). A statistically relevant increase in ear thickness was not observed.
Any other information on results incl. tables
Calculation and Results of Individual Data
Test item concentration |
DPM values measured |
DPM−BG per animal (2 lymph nodes)a |
S.I.b |
||
% |
Group no. |
Animal no. |
|
||
--- |
--- |
BG I |
16 |
--- |
|
--- |
--- |
BG II |
19 |
--- |
--- |
0 |
1 |
1 |
1775 |
1757.5 |
--- |
1 |
2 |
2846 |
2828.5 |
--- |
|
1 |
3 |
2562 |
2544.5 |
--- |
|
1 |
4 |
3937 |
3919.5 |
--- |
|
1 |
5 |
4151 |
4133.5 |
--- |
|
0.01 |
2 |
6 |
2170 |
2152.5 |
0.7 |
2 |
7 |
1759 |
1741.5 |
0.6 |
|
2 |
8 |
1868 |
1850.5 |
0.6 |
|
2 |
9 |
2542 |
2524.5 |
0.8 |
|
2 |
10 |
3085 |
3067.5 |
1 |
|
0.05 |
3 |
11 |
2347 |
2329.5 |
0.8 |
3 |
12 |
2161 |
2143.5 |
0.7 |
|
3 |
13 |
1196 |
1178.5 |
0.4 |
|
3 |
14 |
835 |
817.5 |
0.3 |
|
3 |
15 |
837 |
819.5 |
0.3 |
|
0.25 |
4 |
16 |
422 |
404.5 |
0.1 |
4 |
17 |
867 |
849.5 |
0.3 |
|
4 |
18 |
667 |
649.5 |
0.2 |
|
4 |
19 |
952 |
934.5 |
0.3 |
|
4 |
20 |
976 |
958.5 |
0.3 |
|
BG = Background (1 ml 5% trichloroacetic acid) in duplicate |
|||||
1 = Control Group for the test item and for the positive control item |
Applicant's summary and conclusion
- Interpretation of results:
- other: Not a skin sensitizer under the test conditions of this study
- Conclusions:
- The test item 1,2 Ethylenediamine,N-(2-Aminoethyl)-, reaction products with glycidyl Ph ether was not a skin sensitiser under the test conditions of this study.
- Executive summary:
In the study the test item 1,2 Ethylenediamine,N-(2-Aminoethyl)-, reaction products with glycidyl Ph ether formulated in DMSO (dimethylsulfoxide) was assessed for its possible skin sensitising potential.
For this purpose a local lymph node assay was performed using test item concentrations of 0.01, 0.05, and 0.25%. The highest concentration tested was the highest concentration that could be achieved whilst avoiding systemic toxicity and excessive local skin irritation as confirmed by four pre-experiments.
The animals did not show any signs of systemic toxicity during the course of the study and no cases of mortality were observed. From days 1 to 6, the animals showed an erythema of the ear skin (Score 1). Additionally, on day 6, scaly ears and erythema was observed.
In this study Stimulation Indices (S.I.) of 0.7, 0.5, and 0.3 were determined with the test item at concentrations of 0.01, 0.05, and 0.25% in DMSO, respectively.
Conclusion: The test item 1,2 Ethylenediamine,N-(2-Aminoethyl)-, reaction products with glycidyl Ph ether was not a skin sensitiser under the test conditions of this study.
.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.